BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 38218417)

  • 1. Optimised protocols to generate high titre lentiviral vectors using a novel transfection agent enabling extended HEK293T culture following transient transfection and suspension culture.
    Suleman S; Fawaz S; Roberts T; Ellison S; Bigger B; Themis M
    J Virol Methods; 2024 Apr; 325():114884. PubMed ID: 38218417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation of stable suspension producer cell lines for serum-free lentivirus production.
    Klimpel M; Terrao M; Bräuer M; Dersch H; Biserni M; Melo Do Nascimento L; Schwingal S; Vogel JE; Ferlemann C; Brandt T; Lal NI; Bridgeman K; Petzke A; McDwyer E; Lim JL; Oh S; Brumatti G; Garcia Minambres A; Otte E; Noll T; Pirzas V; Laux H
    Biotechnol J; 2024 May; 19(5):e2400090. PubMed ID: 38719592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transition from serum-supplemented monolayer to serum-free suspension lentiviral vector production for generation of chimeric antigen receptor T cells.
    Tirapelle MC; Oliveira Lomba AL; Silvestre RN; Mizukami A; Covas DT; Picanço-Castro V; Swiech K
    Cytotherapy; 2022 Aug; 24(8):850-860. PubMed ID: 35643755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Scalable Lentiviral Vector Production Using Stable HEK293SF Producer Cell Lines.
    Manceur AP; Kim H; Misic V; Andreev N; Dorion-Thibaudeau J; Lanthier S; Bernier A; Tremblay S; Gélinas AM; Broussau S; Gilbert R; Ansorge S
    Hum Gene Ther Methods; 2017 Dec; 28(6):330-339. PubMed ID: 28826344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a scalable process for high-yield lentiviral vector production by transient transfection of HEK293 suspension cultures.
    Ansorge S; Lanthier S; Transfiguracion J; Durocher Y; Henry O; Kamen A
    J Gene Med; 2009 Oct; 11(10):868-76. PubMed ID: 19618482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Production of lentiviral vectors by large-scale transient transfection of suspension cultures and affinity chromatography purification.
    Segura MM; Garnier A; Durocher Y; Coelho H; Kamen A
    Biotechnol Bioeng; 2007 Nov; 98(4):789-99. PubMed ID: 17461423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Production of lentiviral vectors for transducing cells from the central nervous system.
    Li M; Husic N; Lin Y; Snider BJ
    J Vis Exp; 2012 May; (63):e4031. PubMed ID: 22664962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of lentiviral vector production using microwell suspension cultures of HEK293T-derived producer cells.
    Guy HM; McCloskey L; Lye GJ; Mitrophanous KA; Mukhopadhyay TK
    Hum Gene Ther Methods; 2013 Apr; 24(2):125-39. PubMed ID: 23461548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Production of Recombinant Adeno-associated Virus Vectors Using Suspension HEK293 Cells and Continuous Harvest of Vector From the Culture Media for GMP FIX and FLT1 Clinical Vector.
    Grieger JC; Soltys SM; Samulski RJ
    Mol Ther; 2016 Feb; 24(2):287-297. PubMed ID: 26437810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-Titer Production of HIV-Based Lentiviral Vectors in Roller Bottles for Gene and Cell Therapy.
    Olgun HB; Tasyurek HM; Sanlioglu AD; Sanlioglu S
    Methods Mol Biol; 2019; 1879():323-345. PubMed ID: 29797007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Large-scale production means for the manufacturing of lentiviral vectors.
    Schweizer M; Merten OW
    Curr Gene Ther; 2010 Dec; 10(6):474-86. PubMed ID: 21054245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Production and purification of lentiviral vectors generated in 293T suspension cells with baculoviral vectors.
    Lesch HP; Laitinen A; Peixoto C; Vicente T; Makkonen KE; Laitinen L; Pikkarainen JT; Samaranayake H; Alves PM; Carrondo MJ; Ylä-Herttuala S; Airenne KJ
    Gene Ther; 2011 Jun; 18(6):531-8. PubMed ID: 21248790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Production of Lentiviral Vectors Using Suspension Cells Grown in Serum-free Media.
    Bauler M; Roberts JK; Wu CC; Fan B; Ferrara F; Yip BH; Diao S; Kim YI; Moore J; Zhou S; Wielgosz MM; Ryu B; Throm RE
    Mol Ther Methods Clin Dev; 2020 Jun; 17():58-68. PubMed ID: 31890741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploring nutrient supplementation and bioprocess optimization to improve the production of lentiviral vectors in serum-free medium suspension cultures.
    Vaz TA; Rodrigues AF; Coroadinha AS
    Biotechnol J; 2024 Jan; 19(1):e2300212. PubMed ID: 37903159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a perfusion process for continuous lentivirus production using stable suspension producer cell lines.
    Klimpel M; Terrao M; Ching N; Climenti V; Noll T; Pirzas V; Laux H
    Biotechnol Bioeng; 2023 Sep; 120(9):2622-2638. PubMed ID: 37148430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simplified lentivirus vector production in protein-free media using polyethylenimine-mediated transfection.
    Kuroda H; Kutner RH; Bazan NG; Reiser J
    J Virol Methods; 2009 May; 157(2):113-21. PubMed ID: 19114057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lentiviral Vector Production in Suspension Culture Using Serum-Free Medium for the Transduction of CAR-T Cells.
    Do Minh A; Tran MY; Kamen AA
    Methods Mol Biol; 2020; 2086():77-83. PubMed ID: 31707669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A robust transfection reagent for the transfection of CHO and HEK293 cells and production of recombinant proteins and lentiviral particles - PTG1.
    Gonçalves C; Gross F; Guégan P; Cheradame H; Midou P
    Biotechnol J; 2014 Nov; 9(11):1380-8. PubMed ID: 25215936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Scalable Lentiviral Vector Production and Purification Method Using Mustang Q Chromatography and Tangential Flow Filtration.
    Tinch S; Szczur K; Swaney W; Reeves L; Witting SR
    Methods Mol Biol; 2019; 1937():135-153. PubMed ID: 30706394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genome editing for scalable production of alloantigen-free lentiviral vectors for
    Milani M; Annoni A; Bartolaccini S; Biffi M; Russo F; Di Tomaso T; Raimondi A; Lengler J; Holmes MC; Scheiflinger F; Lombardo A; Cantore A; Naldini L
    EMBO Mol Med; 2017 Nov; 9(11):1558-1573. PubMed ID: 28835507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.